About EnSite X EP System | Abbott
CARDIOVASCULAR
hamburger

Powerful. Reliable. Efficient.

We create bold solutions to challenge AFib. You rely on technology bold enough not to compromise between efficiency and accuracy. With this technology that boldly redefines the EP Lab, you can elevate your practice and meet today’s challenges.

Revolutionize high-density cardiac mapping with the EnSite™ X EP System and EnSite™ Omnipolar Technology (OT) – a next generation 3D mapping platform created to give you a POWERFUL, RELIABLE and EFFICIENT user experience for every procedure.

Map Any Arrhythmia Without Compromise

Introduction to EnSite X EP System and EnSite OT

 

Powerful

Unleash the power of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ and EnSite OT to revolutionize high density mapping.

  • Identify true, local annotation-independent tissue characteristics1
  • See every signal in 360 degrees, capturing signals that no other mapping technology can see**
  • Gain instant new perspective of wavefront direction with activation direction arrows displayed beat by beat
  • Enhance map accuracy with 3x increase in point density per acquisition1***
  • With EnSite™ X Software Version 2, EnSite X EP System is the first and only system to annotate early and late omnipolar signals
 EnSite Electrogram





AFib is a growing crisis in Electrophysiology (EP). This condition affects more than 37 million people.2 We create bold solutions to challenge AFib. This is a suite technology that boldly redefines the EP Lab. Clinical support that elevates your practice to meet today’s challenges. It is a partnership to drive impact and grow the EP community.

 

Reliable

Trust Model and Location Accuracy Over Time

EnSite X Cardiac Voxel Map Comparison A
CT Image
EnSite X Cardiac Voxel Map Comparison B
Model accuracy with EnSite VoXel Mode

Overcome stability challenges with changes in patient management and EP lab environment variables, using the EnSite™ VoXel Mode.

  • Minimize case disruption due to patient movement, even after cardioversion
  • Accurately collect data throughout the procedure by reducing the impact of environmental changes caused by metal distortion

 

Cleaner maps with automatic removal of outliers - your map is ready faster with EnSite™ X Software Version 2 and outlier filtering that reduces editing time.

EnSite X Map with Outlier Filter Off
Outlier Filter Off
EnSite X Map with Outlier Filter On
Outlier Filter On


Connect to the Future of Healthcare

ENSITE™ CONNECTED CARE

 

Efficient

Get in and out of your lab faster with software and hardware designed for efficiency.

  • Reduce the number of connections by up to 50% to facilitate a faster, easier system setup
  • 94% of operators saw improved system usability with an optimized software user interface3
  • 93% of users agreed the new system setup allows for faster troubleshooting and minimized downtime3
Two EnSite X EP System Carts and Component Closeup

A System Built to Last

  • Next generation platform with annual software release cadence
  • Enhanced cybersecurity capabilities including access restrictions, white listing and strengthened patient data protection

*EnSite Omnipolar Technology captures true signals independent of catheter orientation relative to the wavefront.
**Every signal can be defined as any signal seen on the RAI window recorded by the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™ when the map polarity is set to omnipolar.
***As compared to the use of traditional bipole mapping.
† Reduction of connections from the patient connecting to the amplifier from 55 (EnSite Precision™ Cardiac Mapping System) to 25 (EnSite™ X EP System) for an AF case.

References

  1. Deno, D. C., Bhaskaran, A., Morgan, D. J., Goksu, F., Batman, K., Olson, G. K., . . . Nanthakumar, K. (2020). High-resolution, live, directional mapping. Heart Rhythm, 17(9), 1621-1628. doi:10.1016/j.hrthm.2020.04.039
  2. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870. Epub 2020 Jan 19. Erratum in: Int J Stroke. 2020 Jan 28;:1747493020905964. PMID: 31955707.
  3. Abbott. Data on File. Document #90471779.
Indications, Safety & Warnings

MAT-2109938 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.